uMethod is a HealthTech company that has a proprietary analytical platform for determining a patient's likelihood to develop dementia and/or alzheimers. uMethod also provides custom treatments for the treatment of these chronic diseases.
uMethod is a HealthTech company that has a proprietary analytical platform for determining a patient's likelihood to develop dementia and/or alzheimers. uMethod also provides custom treatments for the treatment of these chronic diseases.
The Triangle Tweener Fund strategy is to build an index – smaller investments in a relatively large number of companies. At the current fund size this translates to 10-15 investments a quarter, or 40-60 a year. If you’ve been involved with traditional venture funds (picking winners) this pace seems impossible. Trust us, it’s not easy, but it’s definitely possible and the opportunity is there.
